Renowned Hematological Oncologist Works to Advance Patient Care and Improve Therapy Development

UBC logo

Renowned Hematological Oncologist Works to Advance Patient Care and Improve Therapy Development

UBC Welcomes Don Gabriel, MD, PhD, expert in genetic mutations and targeted therapies

The development of innovative therapies calls for innovative teams with clinical expertise, a passion for patient care and the vision to create medicine that has the potential to positively affect patient populations of one to one million. For these reasons, UBC welcomes Don Gabriel , MD, PhD, to our Global Clinical Development & Operations team.

Dr. Gabriel joins UBC as Sr. Director, Medical Oncology & Scientific Strategy, and his responsibilities include:

  • Directing UBC’s oncology program design and development
  • Developing strategic and fully integrated pre- and post-marketing oncology programs for our clients
  • Interpreting cutting edge science and determining the potential impact of new clinical oncology research on medical thinking and practice
  • Using scientific and clinical oncology data to formulate conceptual frameworks and disease management approaches.

Dr. Gabriel has 30+ years of experience in the healthcare industry and has spent much of his career within the Division of Hematology and Department of Medicine at the University of North Carolina-Chapel Hill where he served as Professor of Medicine, Associate Chief of Staff, Assistant Dean for Clinical Services, Acting Chief of Medical Oncology, and Service Chief Liaison of the Division of Hematology/Oncology. He is a nationally known oncology hematologist in stem cell transplant for liquid tumors and selected solid tumors and has served as co- or principal investigator on nearly 40 studies.

Before pursuing a career in medicine, Dr. Gabriel began his graduate studies in biophysics, and his interest in that area has continued, leading him to co-develop an optical laser-based technology used to identify and characterize suspended particles in the blood, including circulating tumors.

Dr. Gabriel’s unique combination of experience in clinical, academic, and entrepreneurial settings within the field of oncology allows him to bring keen insights and expertise to our clients. Are you looking for an oncology expert backed by a Global Clinical Development & Operations team with solid experience in targeted therapies? Contact us to learn more or visit with our team at the American Society of Clinical Oncology’s (ASCO) Annual Meeting, May 30 through June 1 in Chicago. UBC will be at booth #22147 with our partners from Accredo Specialty Pharmacy and CuraScript Specialty Distribution.